Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senator softens on cloning-derived treatments:

This article was originally published in Clinica

Executive Summary

Senator Sam Brownback, sponsor of legislation banning all forms of cloning, even cloning for medical purposes, has reportedly agreed to drop a provision that would impose hefty fines and jail sentences on anyone who imports a medical treatment developed through cloning. The Senate is scheduled to debate the cloning issue in the next few weeks and the outcome is currently considered "too close to call".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel